tradingkey.logo
tradingkey.logo
Search

ATAI Life Sciences NV

ATAI
Add to Watchlist
7.350USD
+0.060+0.82%
Close 09-10 16:00ET
2.72BMarket Cap
LossP/E TTM

ATAI Financials

See ATAI Life Sciences NV's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
2.72B
Dividend TTM
0.00
P/E TTM
-2.58
EPS TTM
-2.85
Revenue
4.09M
Net Profit
-149.27M
ROE
-378.29%
ROA
-288.06%

ATAI Life Sciences NV Earnings Date

Latest Release
Aug 11, 2026
EPS / Forecast
-0.09/-0.10
Revenue / Forecast
1.70M/10.00K

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
36.09%-0.09
44.43%-0.08
-614.36%-1.73
-71.51%-0.28
60.52%-0.14
10.81%-0.15
-122.14%-0.24
-157.63%-0.16
-68.48%-0.36
20.96%-0.17
61.59%-0.11
--0.28
---0.21
---0.21
---0.28
---0.69
----
----
----
----
Revenue
137.00%1.70M
-38.65%954.00K
--1.07M
1772.50%749.00K
163.37%719.00K
--1.56M
----
-54.02%40.00K
58.72%273.00K
-100.00%0.00
-52.63%18.00K
262.50%87.00K
1.18%172.00K
--37.00K
-83.48%38.00K
-90.98%24.00K
--170.00K
-100.00%0.00
--230.00K
--266.00K
Net Profit
-17.29%-32.52M
-12.68%-29.78M
-1298.46%-544.81M
-132.34%-61.07M
51.62%-27.73M
1.06%-26.43M
-112.98%-38.96M
-159.41%-26.29M
-73.45%-57.31M
19.38%-26.71M
59.36%-18.29M
230.56%44.24M
9.77%-33.04M
10.13%-33.13M
49.36%-45.01M
-8.76%-33.89M
24.44%-36.62M
-5458.87%-36.87M
-2.64%-88.88M
62.55%-31.16M
Net Margin
50.50%-1910.09%
-83.55%-3123.90%
---51110.51%
87.60%-8157.28%
81.64%-3858.97%
---1701.93%
----
-231.95%-65777.50%
-7.03%-21014.29%
----
13.37%-106344.44%
--49851.72%
---19634.30%
---92848.65%
---122760.53%
---56804.10%
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
--100.00%
0.00%100.00%
0.00%100.00%
--100.00%
----
0.00%100.00%
0.00%100.00%
----
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
Debt to assets ratio
----
----
-100.00%0.00%
-100.00%0.00%
-62.14%3.26%
66.40%12.15%
142.01%14.74%
130.95%11.51%
42.64%8.60%
34.84%7.30%
23.08%6.09%
--4.99%
--6.03%
--5.42%
--4.95%
--4.38%
----
----
----
----
Revenue
137.00%1.70M
-38.65%954.00K
--1.07M
1772.50%749.00K
163.37%719.00K
--1.56M
----
-54.02%40.00K
58.72%273.00K
-100.00%0.00
-52.63%18.00K
262.50%87.00K
1.18%172.00K
--37.00K
-83.48%38.00K
-90.98%24.00K
--170.00K
-100.00%0.00
--230.00K
--266.00K
Operating profit
-0.66%-25.44M
-60.36%-30.90M
-27.60%-38.62M
-25.81%-28.44M
1.39%-25.27M
13.14%-19.27M
9.82%-30.27M
15.77%-22.60M
19.56%-25.63M
26.08%-22.18M
10.66%-33.56M
30.16%-26.83M
8.97%-31.86M
10.25%-30.01M
2.75%-37.56M
-15.17%-38.42M
34.40%-35.00M
-765.91%-33.44M
48.73%-38.63M
-351.68%-33.36M
Net Profit
-17.29%-32.52M
-12.68%-29.78M
-1298.46%-544.81M
-132.34%-61.07M
51.62%-27.73M
1.06%-26.43M
-112.98%-38.96M
-159.41%-26.29M
-73.45%-57.31M
19.38%-26.71M
59.36%-18.29M
230.56%44.24M
9.77%-33.04M
10.13%-33.13M
49.36%-45.01M
-8.76%-33.89M
24.44%-36.62M
-5458.87%-36.87M
-2.64%-88.88M
62.55%-31.16M
Current assets
138.36%244.75M
115.62%250.07M
244.07%275.68M
14.54%130.67M
-12.91%102.68M
-1.30%115.98M
-56.83%80.13M
-47.15%114.07M
-51.43%117.91M
-56.15%117.50M
-35.37%185.59M
-32.02%215.82M
-24.98%242.77M
-23.18%267.93M
-23.44%287.14M
-28.15%317.48M
-29.28%323.61M
--348.79M
--375.08M
--441.86M
Total current liabilities
11.68%28.53M
-12.41%24.96M
-5.90%23.48M
-15.78%16.54M
44.79%25.55M
89.84%28.50M
24.01%24.95M
-0.26%19.64M
-1.57%17.64M
-24.76%15.01M
1.12%20.12M
-24.00%19.70M
-18.36%17.93M
-9.68%19.95M
-4.96%19.90M
69.18%25.91M
54.79%21.96M
--22.09M
--20.93M
--15.32M
Total assets
39.95%264.79M
35.29%264.88M
83.66%292.72M
21.42%239.82M
-12.32%189.20M
-27.25%195.78M
-45.69%159.39M
-35.92%197.52M
-14.91%215.78M
-4.13%269.12M
-3.92%293.48M
-10.03%308.22M
-27.32%253.59M
-26.85%280.72M
-26.25%305.44M
-29.23%342.60M
-31.04%348.94M
--383.73M
--414.17M
--484.11M
Total liabilities
95.14%88.36M
51.92%66.10M
65.11%70.72M
56.07%79.91M
-4.16%45.28M
-5.13%43.51M
-12.87%42.83M
28.95%51.20M
24.47%47.24M
14.44%45.86M
23.91%49.16M
-14.64%39.71M
31.73%37.96M
36.43%40.08M
40.66%39.67M
117.89%46.52M
36.78%28.81M
--29.38M
--28.21M
--21.35M
Total equity
22.59%176.44M
30.54%198.78M
90.47%222.00M
9.29%159.91M
-14.60%143.93M
-31.79%152.27M
-52.29%116.55M
-45.51%146.32M
-21.84%168.53M
-7.22%223.26M
-8.07%244.32M
-9.31%268.51M
-32.64%215.64M
-32.09%240.64M
-31.14%265.77M
-36.02%296.08M
-33.98%320.12M
--354.36M
--385.96M
--462.76M
Net operating income
-150.27%-35.27M
-18.21%-21.09M
-95.43%-47.48M
-20.27%-23.26M
13.15%-14.09M
20.96%-17.84M
-10.63%-24.30M
-4.94%-19.34M
28.24%-16.23M
-6.93%-22.57M
28.01%-21.96M
34.28%-18.43M
-3.11%-22.61M
11.99%-21.11M
-48.74%-30.50M
0.23%-28.05M
---21.93M
---23.99M
-230.05%-20.51M
-416.25%-28.11M
Net investment
1520.91%158.59M
-96.60%-21.65M
-715.00%-40.34M
-371.95%-67.55M
-39.98%9.78M
-196.02%-11.01M
897.08%6.56M
153.44%24.84M
174.08%16.30M
-28.39%11.47M
-101.03%-823.00K
-170.38%-46.48M
-20.81%-22.00M
107.46%16.02M
264.60%80.05M
10857.33%66.05M
---18.21M
---214.74M
-1157.97%-48.63M
88.58%-614.00K
Net financing
-66.02%2.64M
-98.62%821.00K
92351.30%142.38M
1120.76%59.74M
2279.45%7.76M
--59.60M
101.82%154.00K
--4.89M
426.00%326.00K
-100.00%0.00
-817.68%-8.46M
-100.00%0.00
-105.57%-100.00K
56.06%206.00K
-153.51%-922.00K
410.21%19.78M
--1.79M
--132.00K
-97.90%1.72M
-78.53%3.88M

FAQs

What is the total revenue of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its total revenue reached 4.09M, with a year-on-year change of 308.00K.

What are the current assets of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its current assets were 275.68M, with a year-on-year change of 244.07.

What are the total assets of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its total assets of ATAI Life Sciences NV were 292.72M, with a year-on-year change of 83.66.

What are the total liabilities of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its total liabilities of ATAI Life Sciences NV were 70.72M, with a year-on-year change of 65.11.

What is the total equity of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its total equity of ATAI Life Sciences NV was 222.00M, with a year-on-year change of 90.47.

What is the net operating income of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its net operating income of ATAI Life Sciences NV was -111.26M, with a year-on-year change of -11.49.

What is the net investment of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its net investment of ATAI Life Sciences NV was -109.13M, with a year-on-year change of -284.42.

What is the net financing of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its net financing of ATAI Life Sciences NV was 269.48M, with a year-on-year change of 4914.53.

What is the Earnings Per Share (EPS) of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its Earnings Per Share (EPS) was -2.91, with a year-on-year change of -212.63.

What is the net income of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its net income was -660.05M, with a year-on-year change of -342.19.

What is the net margin of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its net profit margin was -16144.46, with a year-on-year change of 66.86.

What is the Return on Equity (ROE) of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its Return on Equity (ROE) was -390.36, with a year-on-year change of -369.76.

What is the Return on Assets (ROA) of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its Return on Assets (ROA) was -292.03, with a year-on-year change of -340.69.

What is the operating profit of ATAI Life Sciences NV?

According to ATAI Life Sciences NV's FY2025 earnings report, its operating profit was -111.26M, with a year-on-year change of -11.49.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.